Jump Financial, LLC Cardiff Oncology, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.05 - $2.77 $175,967 - $237,771	-85,838 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$2.22 - $5.89 $190,560 - $505,585	85,838 New	85,838 $190,000
Q2 2022 Aug 09, 2022	SELL	$1.17 - $2.61 $48,672 - $108,576	-41,600 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.11 - $7.25 $87,776 - $301,600	41,600 New	41,600 $103,000
Q3 2021 Nov 12, 2021	SELL	$5.01 - $7.58 $220,941 - $334,278	-44,100 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.65 - $10.04 $293,265 - $442,763	44,100 New	44,100 $293,000

12.3M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $185M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.